Amanote Research
Register
Sign In
056 IgG Galactosylation Levels Are Decreased in Systemic Sclerosis Patients and Differ According to Disease Sub-Classification
Journal of Investigative Dermatology
- United Kingdom
doi 10.1016/j.jid.2019.03.132
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Date
May 1, 2019
Authors
Q. Liu
J. Lin
W. Pu
Y. Ma
J. Wang
W. Wu
Publisher
Elsevier BV
Related search
Serum Levels of Soluble Carbonic Anhydrase IX Are Decreased in Patients With Diffuse Cutaneous Systemic Sclerosis Compared to Those With Limited Cutaneous Systemic Sclerosis
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
Decreased Levels of Autoantibody Against Histone Deacetylase 3 in Patients With Systemic Sclerosis
Autoimmunity
Allergy
Immunology
Treatment Algorithms for Systemic Sclerosis According to Experts
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Serum Amylase Levels Are Decreased in Chinese Non-Alcoholic Fatty Liver Disease Patients
Lipids in Health and Disease
Biochemistry
Endocrinology
Clinical Biochemistry
Metabolism
Diabetes
Clinical Association of Serum Interleukin-17 Levels in Systemic Sclerosis: Is Systemic Sclerosis a Th17 Disease?
Journal of Dermatological Science
Dermatology
Biochemistry
Molecular Biology
Serum Levels of Leptin Receptor in Patients With Systemic Sclerosis
Intractable and Rare Diseases Research
Medicine
IgG Fc Galactosylation Predicts Response to Methotrexate in Early Rheumatoid Arthritis
Arthritis Research & Therapy
Serum IgG Antibody Levels to Periodontal Microbiota Are Associated With Incident Alzheimer Disease
PLoS ONE
Multidisciplinary
Capillaroscopy Changes Are Associated With Disease Progression in Patients With Early Systemic Sclerosis: A Prospective Study
International Journal of Rheumatic Diseases
Rheumatology
